Co-Authors
This is a "connection" page, showing publications co-authored by Cassandra Josephson and John Roback.
Connection Strength
1.294
-
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease. Blood Adv. 2020 09 22; 4(18):4278-4281.
Score: 0.226
-
Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants. Transfusion. 2019 05; 59(5):1675-1682.
Score: 0.203
-
Does red blood cell irradiation and/or anemia trigger intestinal injury in premature infants with birth weight = 1250 g? An observational birth cohort study. BMC Pediatr. 2018 08 11; 18(1):270.
Score: 0.195
-
Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience. Arch Pathol Lab Med. 2017 Mar; 141(3):329-340.
Score: 0.177
-
COVID-19 convalescent plasma donor recruitment experience from the perspective of a hospital transfusion medicine service. Transfusion. 2021 07; 61(7):2213-2215.
Score: 0.059
-
Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma. Transfusion. 2021 06; 61(6):1740-1748.
Score: 0.059
-
Comparison of Antibody Class-Specific SARS-CoV-2 Serologies for the Diagnosis of Acute COVID-19. J Clin Microbiol. 2021 03 19; 59(4).
Score: 0.058
-
The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A. Blood Adv. 2021 03 09; 5(5):1305-1309.
Score: 0.058
-
An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay. Immunohematology. 2021 Mar; 37(1):33-43.
Score: 0.058
-
Therapeutic plasma exchange for COVID-19-associated hyperviscosity. Transfusion. 2021 04; 61(4):1029-1034.
Score: 0.057
-
Anemia induces gut inflammation and injury in an animal model of preterm infants. Transfusion. 2019 04; 59(4):1233-1245.
Score: 0.051
-
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 05; 24(5):973-982.
Score: 0.047
-
Daratumumab (anti-CD38) induces loss of CD38 on red blood cells. Blood. 2017 06 01; 129(22):3033-3037.
Score: 0.044